Koninklijke Philips N.V. (PHIA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
62
About the Report
About the Report
Summary
Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions. It also offers mother and child care, and oral healthcare products include male grooming and beauty products kitchen appliance, coffee, air, garment care, and floor care products and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The company provides health & wellness, personal care and domestic appliances. Philips offers consumer luminaires, lumileds, professional lighting solutions, light sources & electronics and automotive lighting. It has operational presence in both mature and growth geographies. The company caters to Healthcare, Consumer Life Style, and Lighting industries. Philips is headquartered in Amsterdam, the Netherlands.
Koninklijke Philips N.V. (PHIA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Koninklijke Philips N.V., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Biocartis Raises USD 40.5 Million In Series E Financing 13
NightBalance Raises Funds in Second Round of Financing 15
NightBalance Raises Funds Through Venture Financing 16
Biocartis Raises USD 44.7 Million In Series D Financing 17
Partnerships 19
Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19
Koninklijke Philips Enters into Agreement with Illumina 20
Ion Beam Applications Enters into Agreement with Philips Healthcare 21
Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23
Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24
Debt Offering 25
Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25
Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26
Acquisition 27
Philips to Acquire Unisensor, Analytical Instrument Provider 27
Zambon Acquires Profile Pharma from Philips 28
Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To USD 42.1 Million 29
Koninklijke Philips N.V.-Key Competitors 32
Koninklijke Philips N.V.-Key Employees 33
Koninklijke Philips N.V.-Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 37
Recent Developments 38
Strategy And Business Planning 38
Aug 24, 2017: Governor Haslam, Commissioner Rolfe Announce Philips to Establish Business Center of Expertise in Middle Tennessee 38
Financial Announcements 39
Jul 23, 2018: Philips reports Second Quarter Results 2018 39
Apr 23, 2018: Philips First Quarter Results 2018 41
Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017 43
Oct 23, 2017: Philips' Third Quarter Results 2017 46
Jul 24, 2017: Philips' Second Quarter Results 2017 48
Corporate Communications 51
Oct 20, 2017: Extraordinary General Meeting of Shareholders appoints Marnix van Ginneken to Philips' Board of Management 51
Sep 18, 2017: Philips Steps Up Commitment to Ensuring Healthy Lives for All During United Nations General Assembly Week 52
Jul 20, 2017: Chief Business Leader of Philips' Personal Health businesses Pieter Nota to leave company 53
Government and Public Interest 54
Nov 23, 2017: Philips-led research consortium awarded EUR 6.3 million EU grant to develop integrated approaches for personalized cancer treatment 54
Apr 21, 2017: New study with Philips Trilogy reveals payers and hospitals can save millions in readmission costs, hospitalization rates for COPD patients 55
Product News 57
Jun 09, 2017: Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices 57
Other Significant Developments 58
Oct 05, 2018: Philips launches Ambient Experience preparation & recovery bay to support patients and staff before and after medical procedures 58
Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders 59
Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York 60
Sep 14, 2017: Philips reaffirms commitment to patient safety by joining coalition to advance quality and safety in healthcare 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
List of Figure
List of Figures
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Key Facts, 2017 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Koninklijke Philips N.V., Deals By Therapy Area, 2012 to YTD 2018 9
Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Biocartis Raises USD 40.5 Million In Series E Financing 13
NightBalance Raises Funds in Second Round of Financing 15
NightBalance Raises Funds Through Venture Financing 16
Biocartis Raises USD 44.7 Million In Series D Financing 17
Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19
Koninklijke Philips Enters into Agreement with Illumina 20
Ion Beam Applications Enters into Agreement with Philips Healthcare 21
Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23
Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24
Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25
Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26
Philips to Acquire Unisensor, Analytical Instrument Provider 27
Zambon Acquires Profile Pharma from Philips 28
Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To USD 42.1 Million 29
Koninklijke Philips N.V., Key Competitors 32
Koninklijke Philips N.V., Key Employees 33
Koninklijke Philips N.V., Subsidiaries 34
Koninklijke Philips N.V., Joint Venture 37
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.